Artivion, Inc. (AORT)
USD 22.19
(-3.9%)
USD 22.19
(-3.9%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 792.39 Million USD | 3.88% |
| 2022 | 762.79 Million USD | -3.81% |
| 2021 | 793.05 Million USD | 0.46% |
| 2020 | 789.4 Million USD | 30.34% |
| 2019 | 605.65 Million USD | 6.05% |
| 2018 | 571.09 Million USD | -3.48% |
| 2017 | 591.67 Million USD | 87.15% |
| 2016 | 316.14 Million USD | 74.49% |
| 2015 | 181.17 Million USD | 2.85% |
| 2014 | 176.15 Million USD | 0.84% |
| 2013 | 174.68 Million USD | 11.15% |
| 2012 | 157.15 Million USD | 6.28% |
| 2011 | 147.86 Million USD | 7.59% |
| 2010 | 137.43 Million USD | 2.67% |
| 2009 | 133.85 Million USD | 6.24% |
| 2008 | 125.99 Million USD | 35.94% |
| 2007 | 92.68 Million USD | 16.05% |
| 2006 | 79.86 Million USD | 3.98% |
| 2005 | 76.8 Million USD | 4.84% |
| 2004 | 73.26 Million USD | -2.35% |
| 2003 | 75.02 Million USD | -29.5% |
| 2002 | 106.41 Million USD | -17.71% |
| 2001 | 129.31 Million USD | 15.45% |
| 2000 | 112 Million USD | 19.13% |
| 1999 | 94.02 Million USD | -4.45% |
| 1998 | 98.4 Million USD | 83.24% |
| 1997 | 53.7 Million USD | 53.43% |
| 1996 | 35 Million USD | 48.31% |
| 1995 | 23.6 Million USD | 10.28% |
| 1994 | 21.4 Million USD | 6.47% |
| 1993 | 20.1 Million USD | 62.1% |
| 1992 | 12.4 Million USD | 13.76% |
| 1991 | 10.9 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 784 Million USD | -1.06% |
| 2024 Q2 | 789.53 Million USD | 0.71% |
| 2023 Q2 | 777.86 Million USD | 2.75% |
| 2023 FY | 792.39 Million USD | 3.88% |
| 2023 Q4 | 792.39 Million USD | 2.27% |
| 2023 Q3 | 774.78 Million USD | -0.4% |
| 2023 Q1 | 757.07 Million USD | -0.75% |
| 2022 Q4 | 762.79 Million USD | 2.7% |
| 2022 Q2 | 764.86 Million USD | -2.17% |
| 2022 Q3 | 742.73 Million USD | -2.89% |
| 2022 FY | 762.79 Million USD | -3.81% |
| 2022 Q1 | 781.85 Million USD | -1.41% |
| 2021 Q2 | 810.49 Million USD | 1.97% |
| 2021 Q3 | 818.65 Million USD | 1.01% |
| 2021 Q4 | 793.05 Million USD | -3.13% |
| 2021 Q1 | 794.83 Million USD | 0.69% |
| 2021 FY | 793.05 Million USD | 0.46% |
| 2020 Q4 | 789.4 Million USD | 0.92% |
| 2020 Q1 | 621.03 Million USD | 2.54% |
| 2020 Q3 | 782.2 Million USD | 12.83% |
| 2020 Q2 | 693.25 Million USD | 11.63% |
| 2020 FY | 789.4 Million USD | 30.34% |
| 2019 FY | 605.65 Million USD | 6.05% |
| 2019 Q2 | 597.12 Million USD | 1.74% |
| 2019 Q4 | 605.65 Million USD | 2.2% |
| 2019 Q3 | 592.6 Million USD | -0.76% |
| 2019 Q1 | 586.92 Million USD | 2.77% |
| 2018 Q4 | 571.09 Million USD | 0.25% |
| 2018 Q3 | 569.69 Million USD | -0.13% |
| 2018 FY | 571.09 Million USD | -3.48% |
| 2018 Q2 | 570.44 Million USD | -2.18% |
| 2018 Q1 | 583.17 Million USD | -1.44% |
| 2017 Q3 | 326.14 Million USD | 1.22% |
| 2017 Q1 | 319.36 Million USD | 1.02% |
| 2017 Q2 | 322.22 Million USD | 0.89% |
| 2017 FY | 591.67 Million USD | 87.15% |
| 2017 Q4 | 591.67 Million USD | 81.42% |
| 2016 FY | 316.14 Million USD | 74.49% |
| 2016 Q3 | 308.85 Million USD | 1.92% |
| 2016 Q2 | 303.03 Million USD | 1.98% |
| 2016 Q1 | 297.15 Million USD | 64.01% |
| 2016 Q4 | 316.14 Million USD | 2.36% |
| 2015 Q4 | 181.17 Million USD | 0.67% |
| 2015 FY | 181.17 Million USD | 2.85% |
| 2015 Q1 | 173.2 Million USD | -1.68% |
| 2015 Q2 | 176.06 Million USD | 1.65% |
| 2015 Q3 | 179.98 Million USD | 2.22% |
| 2014 Q2 | 173.81 Million USD | 0.17% |
| 2014 Q4 | 176.15 Million USD | 0.57% |
| 2014 FY | 176.15 Million USD | 0.84% |
| 2014 Q3 | 175.16 Million USD | 0.77% |
| 2014 Q1 | 173.51 Million USD | -0.67% |
| 2013 Q2 | 157.79 Million USD | 2.66% |
| 2013 Q3 | 163.19 Million USD | 3.42% |
| 2013 FY | 174.68 Million USD | 11.15% |
| 2013 Q4 | 174.68 Million USD | 7.04% |
| 2013 Q1 | 153.71 Million USD | -2.19% |
| 2012 Q1 | 147.87 Million USD | 0.01% |
| 2012 Q4 | 157.15 Million USD | 2.39% |
| 2012 Q2 | 156.5 Million USD | 5.84% |
| 2012 Q3 | 153.49 Million USD | -1.93% |
| 2012 FY | 157.15 Million USD | 6.28% |
| 2011 Q3 | 147.99 Million USD | 4.04% |
| 2011 FY | 147.86 Million USD | 7.59% |
| 2011 Q4 | 147.86 Million USD | -0.09% |
| 2011 Q2 | 142.25 Million USD | 3.07% |
| 2011 Q1 | 138.01 Million USD | 0.42% |
| 2010 FY | 137.43 Million USD | 2.67% |
| 2010 Q1 | 137.34 Million USD | 2.6% |
| 2010 Q2 | 140.2 Million USD | 2.09% |
| 2010 Q4 | 137.43 Million USD | 2.18% |
| 2010 Q3 | 134.5 Million USD | -4.07% |
| 2009 Q1 | 127.39 Million USD | 1.11% |
| 2009 Q4 | 133.85 Million USD | 0.42% |
| 2009 Q3 | 133.29 Million USD | 1.87% |
| 2009 Q2 | 130.84 Million USD | 2.71% |
| 2009 FY | 133.85 Million USD | 6.24% |
| 2008 Q1 | 90.87 Million USD | -1.95% |
| 2008 Q4 | 125.99 Million USD | 22.31% |
| 2008 FY | 125.99 Million USD | 35.94% |
| 2008 Q3 | 103.01 Million USD | 5.02% |
| 2008 Q2 | 98.09 Million USD | 7.94% |
| 2007 Q4 | 92.68 Million USD | 1.97% |
| 2007 FY | 92.68 Million USD | 16.05% |
| 2007 Q1 | 83.41 Million USD | 4.45% |
| 2007 Q2 | 87.67 Million USD | 5.11% |
| 2007 Q3 | 90.89 Million USD | 3.67% |
| 2006 Q1 | 77.08 Million USD | 0.36% |
| 2006 FY | 79.86 Million USD | 3.98% |
| 2006 Q4 | 79.86 Million USD | -0.74% |
| 2006 Q3 | 80.46 Million USD | 3.87% |
| 2006 Q2 | 77.46 Million USD | 0.49% |
| 2005 Q3 | 93.23 Million USD | -9.81% |
| 2005 Q2 | 103.36 Million USD | 9.26% |
| 2005 Q1 | 94.6 Million USD | 29.14% |
| 2005 FY | 76.8 Million USD | 4.84% |
| 2005 Q4 | 76.8 Million USD | -17.61% |
| 2004 FY | 73.26 Million USD | -2.35% |
| 2004 Q3 | 78.52 Million USD | -10.51% |
| 2004 Q2 | 87.75 Million USD | 0.27% |
| 2004 Q4 | 73.26 Million USD | -6.7% |
| 2004 Q1 | 87.51 Million USD | 16.65% |
| 2003 Q1 | 100.54 Million USD | -5.51% |
| 2003 FY | 75.02 Million USD | -29.5% |
| 2003 Q4 | 75.02 Million USD | -13.29% |
| 2003 Q3 | 86.52 Million USD | -8.93% |
| 2003 Q2 | 95 Million USD | -5.51% |
| 2002 Q2 | 130.35 Million USD | -1.74% |
| 2002 Q1 | 132.66 Million USD | 2.6% |
| 2002 Q3 | 107.43 Million USD | -17.58% |
| 2002 FY | 106.41 Million USD | -17.71% |
| 2002 Q4 | 106.41 Million USD | -0.95% |
| 2001 Q4 | 129.31 Million USD | 5.49% |
| 2001 Q2 | 120.14 Million USD | 4.67% |
| 2001 Q3 | 122.57 Million USD | 2.03% |
| 2001 Q1 | 114.78 Million USD | 2.48% |
| 2001 FY | 129.31 Million USD | 15.45% |
| 2000 Q3 | 108.16 Million USD | 8.44% |
| 2000 Q1 | 95.99 Million USD | 2.1% |
| 2000 FY | 112 Million USD | 19.13% |
| 2000 Q4 | 112 Million USD | 3.56% |
| 2000 Q2 | 99.74 Million USD | 3.91% |
| 1999 Q4 | 94.02 Million USD | -3.96% |
| 1999 Q2 | 97.5 Million USD | 0.21% |
| 1999 Q1 | 97.3 Million USD | -1.12% |
| 1999 FY | 94.02 Million USD | -4.45% |
| 1999 Q3 | 97.9 Million USD | 0.41% |
| 1998 Q3 | 102.1 Million USD | 9.78% |
| 1998 Q2 | 93 Million USD | -5.68% |
| 1998 FY | 98.4 Million USD | 83.24% |
| 1998 Q1 | 98.6 Million USD | 83.61% |
| 1998 Q4 | 98.4 Million USD | -3.62% |
| 1997 Q2 | 47.9 Million USD | 1.7% |
| 1997 Q3 | 51.7 Million USD | 7.93% |
| 1997 Q4 | 53.7 Million USD | 3.87% |
| 1997 Q1 | 47.1 Million USD | 34.57% |
| 1997 FY | 53.7 Million USD | 53.43% |
| 1996 Q4 | 35 Million USD | 9.03% |
| 1996 Q1 | 25.1 Million USD | 6.36% |
| 1996 FY | 35 Million USD | 48.31% |
| 1996 Q2 | 27 Million USD | 7.57% |
| 1996 Q3 | 32.1 Million USD | 18.89% |
| 1995 Q3 | 24.2 Million USD | 4.31% |
| 1995 Q4 | 23.6 Million USD | -2.48% |
| 1995 Q2 | 23.2 Million USD | 4.5% |
| 1995 FY | 23.6 Million USD | 10.28% |
| 1995 Q1 | 22.2 Million USD | 3.74% |
| 1994 Q2 | 20.6 Million USD | 1.48% |
| 1994 Q3 | 20.8 Million USD | 0.97% |
| 1994 Q4 | 21.4 Million USD | 2.88% |
| 1994 FY | 21.4 Million USD | 6.47% |
| 1994 Q1 | 20.3 Million USD | 1.0% |
| 1993 Q2 | 19 Million USD | 0.0% |
| 1993 FY | 20.1 Million USD | 62.1% |
| 1993 Q4 | 20.1 Million USD | 2.03% |
| 1993 Q3 | 19.7 Million USD | 3.68% |
| 1992 FY | 12.4 Million USD | 13.76% |
| 1992 Q4 | 12.4 Million USD | 0.0% |
| 1991 FY | 10.9 Million USD | 0.0% |
| 1991 Q4 | 10.9 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Abbott Laboratories | 73.21 Billion USD | 98.918% |
| Allurion Technologies Inc. | 71.71 Million USD | -1004.971% |
| Avanos Medical, Inc. | 1.69 Billion USD | 53.179% |
| Butterfly Network, Inc. | 304.27 Million USD | -160.422% |
| Butterfly Network, Inc. | 304.27 Million USD | -160.422% |
| Bio-Rad Laboratories, Inc. | 12.29 Billion USD | 93.557% |
| Boston Scientific Corporation | 35.13 Billion USD | 97.745% |
| CONMED Corporation | 2.3 Billion USD | 65.548% |
| Edwards Lifesciences Corporation | 9.36 Billion USD | 91.537% |
| Paragon 28, Inc. | 340.69 Million USD | -132.58% |
| Glaukos Corporation | 940.41 Million USD | 15.74% |
| Globus Medical, Inc. | 5.08 Billion USD | 84.42% |
| Inspire Medical Systems, Inc. | 676.81 Million USD | -17.078% |
| Integer Holdings Corporation | 2.94 Billion USD | 73.072% |
| Medtronic plc | 89.98 Billion USD | 99.119% |
| Myomo, Inc. | 14.58 Million USD | -5334.237% |
| Nevro Corp. | 635.71 Million USD | -24.647% |
| Owlet, Inc. | 44.12 Million USD | -1695.882% |
| Penumbra, Inc. | 1.55 Billion USD | 49.085% |
| Vicarious Surgical Inc. | 119.86 Million USD | -561.08% |
| Smith & Nephew plc | 9.98 Billion USD | 92.066% |
| Sonendo, Inc. | 78.16 Million USD | -913.814% |
| STERIS plc | 11.06 Billion USD | 92.838% |
| Stryker Corporation | 39.91 Billion USD | 98.015% |
| Vapotherm, Inc. | 77.61 Million USD | -920.907% |
| Zimmer Biomet Holdings, Inc. | 21.49 Billion USD | 96.314% |